Amrize (AMRZ) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Apr, 2026Executive summary
Revenues increased 0.9% year-over-year to $11.8B in FY 2025, with adjusted EBITDA of $3.0B and net income of $1.2B, supported by strong cash flow and a 49% cash conversion rate.
Net leverage ratio improved to 1.1x, providing flexibility for growth investments and shareholder returns.
Shareholder returns included a $1B share repurchase authorization, a special one-time dividend of $0.44/share, and an annual ordinary dividend of $0.44/share, both subject to shareholder approval.
Significant investments in production capacity and efficiency, including major plant expansions and the acquisition of PB Materials in West Texas.
Completed spin-off and invested in growth initiatives, including new facilities and acquisitions.
Financial highlights
Q4 2025 revenues were $2.84B, down 0.4% year-over-year; Building Materials Q4 revenues grew 3.9% to $2.16B, with adjusted EBITDA up 5.9% to $705M.
Building Envelope Q4 revenues declined 11.8% to $678M, with adjusted EBITDA down 23.5% to $130M, mainly due to soft residential roofing demand.
Full-year free cash flow was $1.5B, with a 49% cash conversion rate.
FY 2025 adjusted EBITDA margin was 25.5%.
CapEx increased 23% to $788M in 2025.
Outlook and guidance
2026 guidance targets $12.29B–$12.52B in revenue (+4% to +6%) and $3.25B–$3.34B in adjusted EBITDA (+8% to +11%), including PB Materials acquisition.
Cement pricing expected to rise low single digits; aggregates mid-single digits; positive volume growth anticipated for both.
Building Envelope expects low single-digit commercial roofing volume growth and flat residential volumes, with improvement in the second half.
Aspire program to deliver 70 bps margin expansion in 2026 and $250M in synergies by 2028.
Net leverage ratio expected to remain below 1.5x.
Latest events from Amrize
- Q1 2026 revenue up 4.7%, Building Materials strong, 2026 guidance and buyback reaffirmed.AMRZ
Q1 202629 Apr 2026 - 2026 AGM proxy covers key votes, governance, compensation, and ESG priorities.AMRZ
Proxy Filing12 Mar 2026 - AGM to address board elections, executive pay, distributions, and non-financial reporting.AMRZ
Proxy Filing12 Mar 2026 - 2026 AGM proxy covers financials, compensation, board elections, and strong governance initiatives.AMRZ
Proxy Filing27 Feb 2026 - Stable Q2 2025 results and synergy program support strong outlook and long-term growth.AMRZ
Q2 202523 Nov 2025 - Q3 revenue up 6.6% to $3,675M, net income $543M, 2025 guidance raised to $12.0B.AMRZ
Q3 202529 Oct 2025